Literature DB >> 23860656

Protein tyrosine phosphatases: structure, function, and implication in human disease.

Lutz Tautz1, David A Critton, Stefan Grotegut.   

Abstract

Protein tyrosine phosphorylation is a key regulatory mechanism in eukaryotic cell physiology. Aberrant expression or function of protein tyrosine kinases and protein tyrosine phosphatases can lead to serious human diseases, including cancer, diabetes, as well as cardiovascular, infectious, autoimmune, and neuropsychiatric disorders. Here, we give an overview of the protein tyrosine phosphatase superfamily with its over 100 members in humans. We review their structure, function, and implications in human diseases, and discuss their potential as novel drug targets, as well as current challenges and possible solutions to developing therapeutics based on these enzymes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23860656      PMCID: PMC8158066          DOI: 10.1007/978-1-62703-562-0_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  224 in total

1.  Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A.

Authors:  E B Fauman; J P Cogswell; B Lovejoy; W J Rocque; W Holmes; V G Montana; H Piwnica-Worms; M J Rink; M A Saper
Journal:  Cell       Date:  1998-05-15       Impact factor: 41.582

2.  Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity.

Authors:  N Kashige; N Carpino; R Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

3.  Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition.

Authors:  M Sarmiento; Y A Puius; S W Vetter; Y F Keng; L Wu; Y Zhao; D S Lawrence; S C Almo; Z Y Zhang
Journal:  Biochemistry       Date:  2000-07-18       Impact factor: 3.162

4.  Development of an efficient "substrate-trapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates.

Authors:  Yehenew M Agazie; Michael J Hayman
Journal:  J Biol Chem       Date:  2003-02-11       Impact factor: 5.157

Review 5.  Targeting the PTPome in human disease.

Authors:  Lutz Tautz; Maurizio Pellecchia; Tomas Mustelin
Journal:  Expert Opin Ther Targets       Date:  2006-02       Impact factor: 6.902

Review 6.  Protein tyrosine phosphatases in lymphocyte activation and autoimmunity.

Authors:  Inmoo Rhee; André Veillette
Journal:  Nat Immunol       Date:  2012-04-18       Impact factor: 25.606

Review 7.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  The second domain of the CD45 protein tyrosine phosphatase is critical for interleukin-2 secretion and substrate recruitment of TCR-zeta in vivo.

Authors:  N Kashio; W Matsumoto; S Parker; D M Rothstein
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

9.  Partial trisomy 1q. A nonrandom primary chromosomal abnormality in myelodysplastic syndromes?

Authors:  C Fonatsch; D Haase; M Freund; H Bartels; H Tesch
Journal:  Cancer Genet Cytogenet       Date:  1991-10-15

10.  Germline KRAS mutations cause Noonan syndrome.

Authors:  Suzanne Schubbert; Martin Zenker; Sara L Rowe; Silke Böll; Cornelia Klein; Gideon Bollag; Ineke van der Burgt; Luciana Musante; Vera Kalscheuer; Lars-Erik Wehner; Hoa Nguyen; Brian West; Kam Y J Zhang; Erik Sistermans; Anita Rauch; Charlotte M Niemeyer; Kevin Shannon; Christian P Kratz
Journal:  Nat Genet       Date:  2006-02-12       Impact factor: 38.330

View more
  43 in total

Review 1.  Multiple Functions of the Eya Phosphotyrosine Phosphatase.

Authors:  Ilaria Rebay
Journal:  Mol Cell Biol       Date:  2015-12-14       Impact factor: 4.272

2.  DUSP3 Genetic Deletion Confers M2-like Macrophage-Dependent Tolerance to Septic Shock.

Authors:  Pratibha Singh; Lien Dejager; Mathieu Amand; Emilie Theatre; Maud Vandereyken; Tinatin Zurashvili; Maneesh Singh; Matthias Mack; Steven Timmermans; Lucia Musumeci; Emmanuel Dejardin; Tomas Mustelin; Jo A Van Ginderachter; Michel Moutschen; Cécile Oury; Claude Libert; Souad Rahmouni
Journal:  J Immunol       Date:  2015-04-15       Impact factor: 5.422

3.  Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.

Authors:  Miryam Pastor; Rosalía Fernández-Calle; Bruno Di Geronimo; Marta Vicente-Rodríguez; José María Zapico; Esther Gramage; Claire Coderch; Carmen Pérez-García; Amy W Lasek; Leonor Puchades-Carrasco; Antonio Pineda-Lucena; Beatriz de Pascual-Teresa; Gonzalo Herradón; Ana Ramos
Journal:  Eur J Med Chem       Date:  2017-11-28       Impact factor: 6.514

4.  EYA1's Conformation Specificity in Dephosphorylating Phosphothreonine in Myc and Its Activity on Myc Stabilization in Breast Cancer.

Authors:  Jun Li; Yoel Rodriguez; Chunming Cheng; Lei Zeng; Elaine Y M Wong; Chelsea Y Xu; Ming-Ming Zhou; Pin-Xian Xu
Journal:  Mol Cell Biol       Date:  2016-12-19       Impact factor: 4.272

5.  Allosteric Impact of the Variable Insert Loop in Vaccinia H1-Related (VHR) Phosphatase.

Authors:  Victor A Beaumont; Krystle Reiss; Zexing Qu; Brandon Allen; Victor S Batista; J Patrick Loria
Journal:  Biochemistry       Date:  2020-05-06       Impact factor: 3.162

Review 6.  Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.

Authors:  Lutz Tautz; Yotis A Senis; Cécile Oury; Souad Rahmouni
Journal:  Bioorg Med Chem       Date:  2015-04-04       Impact factor: 3.641

7.  Homozygous truncating PTPRF mutation causes athelia.

Authors:  Guntram Borck; Liat de Vries; Hsin-Jung Wu; Pola Smirin-Yosef; Gudrun Nürnberg; Irina Lagovsky; Luis Henrique Ishida; Patrick Thierry; Dagmar Wieczorek; Peter Nürnberg; John Foley; Christian Kubisch; Lina Basel-Vanagaite
Journal:  Hum Genet       Date:  2014-04-30       Impact factor: 4.132

8.  The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.

Authors:  Anita Szalmás; Vjekoslav Tomaić; Om Basukala; Paola Massimi; Suruchi Mittal; József Kónya; Lawrence Banks
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

9.  Structural and biochemical characterization of Siw14: A protein-tyrosine phosphatase fold that metabolizes inositol pyrophosphates.

Authors:  Huanchen Wang; Chunfang Gu; Ronda J Rolfes; Henning J Jessen; Stephen B Shears
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

10.  PTP1B: a new therapeutic target for Rett syndrome.

Authors:  Lutz Tautz
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.